Alkermes Company Description
Alkermes, whose name is Arabic for "magic potion," is working some biotech alchemy. The firm uses its proprietary drug-delivery systems to make fragile biotech compounds that require less frequent dosing or provide more targeted delivery. It has a couple of drugs on the market that use its injectable extended-release technology, which lets patients take a drug once or twice a month, rather than once or twice a day. One such drug is Risperdal Consta, a long-acting version of Janssen's schizophrenia medication Risperdal. Another is Vivitrol, a treatment for alcohol dependence that partner Cephalon markets in the US.
View the Comprehensive Company Description for Alkermes
The Company Description provides a historical perspective of Alkermes's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Alkermes's evolution in the marketplace.
